Shingles Risk Is Elevated in COPD Patients

March 2011
Pulmonary Reviews;Mar2011, Vol. 16 Issue 3, p23
The article reports on the finding that chronic obstructive pulmonary disease (COPD) patients, especially those on corticosteroids, face greater risk for herpes zoster, compared with the general population.


Related Articles

  • Risk of herpes zoster among patients with chronic obstructive pulmonary disease: a population-based study. Yang, Ya-Wen; Chen, Yi-Hua; Wang, Kuo-Hsien; Wang, Chen-Yi; Lin, Hui-Wen // CMAJ: Canadian Medical Association Journal;3/22/2011, Vol. 183 Issue 5, pE275 

    Background: Systemic inflammation and dysregulated immune function in chronic obstructive pulmonary disease (COPD) is hypothesized to predispose patients to development of herpes zoster. However, the risk of herpes zoster among patients with COPD is undocumented. We therefore aimed to...

  • Using inhaled corticosteroids for treatment of patients with COPD. Walling, Anne D. // American Family Physician;8/1/1998, Vol. 58 Issue 2, p547 

    Relates to a March, 1998 article in the `Lancet' journal by P.L. Paggiaro, et al., which dealt with use of inhaled corticosteroids for the treatment of patients with chronic obstructive pulmonary disease (COPD).

  • Withdrawal of inhaled corticosteroids in individuals with COPD - a systematic review and comment on trial methodology. Nadeem, Nighat J.; Taylor, Stephanie J. C.; Eldridge, Sandra M. // Respiratory Research;Aug2011, Vol. 12 Issue 8, p1 

    Inhaled corticosteroids (ICS) reduce COPD exacerbation frequency and slow decline in health related quality of life but have little effect on lung function, do not reduce mortality, and increase the risk of pneumonia. We systematically reviewed trials in which ICS have been withdrawn from...

  • LABA/ICS Fixed-Dose Combinations Are the Most Commonly Prescribed Maintenance Therapies for Newly Diagnosed COPD Patients.  // Biomedical Market Newsletter;6/1/2012, Vol. 21, p1 

    The article focuses on the research analysis titled "Treatment Algorithms in Chronic Obstructive Pulmonary Disease," from BioTrends Research Group LLC. The research finds that finds that long-acting beta2 agonist (LABA) and inhaled corticosteroid (ICS) fixed-dose combinations are the most...

  • Evaluation of Inhaled Corticosteroid Efficacy by Electron Microscopy in Patients with Chronic Obstructive Pulmonary Disease. Pınar Taştan, Çağla; Mine Erbil, Kadriye; Ulusal Okyay, Gülay; Ardıç, Sadık // Turkish Respiratory Journal / Solunum Dergisi;2013, Vol. 15 Issue 3, p149 

    Objective: Inhaled corticosteroids definitely alleviate bronchial mucosal inflammation in patients with asthma. Nevertheless, the data regarding their anti-inflammatory effects in patients with chronic obstructive pulmonary disease (COPD) is controversial. The aim of the present study is to...

  • Tiotropium bromide.  // Reactions Weekly;2/17/2007, Issue 1139, p21 

    The article presents a case study of photosensitive lichenoid eruption in a 72-year-old man, with chronic obstructive pulmonary disease, during treatment with tiotropium bromide. 22 months after tiotropium bromide initiation, the man had polygonal, confluent, flat-topped, well-defined,...

  • Pneumonia and inhaled corticosteroids in COPD. Jabbar, Avais // Thorax;Sep2014, Vol. 69 Issue 9, p872 

    The article focuses on a study on the association between increased risk of pneumonia in patient with chronic obstructive pulmonary disease (COPD) and combined treatment of long-acting β2-agonists and corticosteroids. It says that the risks of pneumonia and related events in patients treated...

  • Steroid Resistance in COPD? Overlap and Differential Anti-Inflammatory Effects in Smokers and Ex-Smokers. Hoonhorst, Susan J. M.; ten Hacken, Nick H. T.; Vonk, Judith M.; Timens, Wim; Hiemstra, Pieter S.; Lapperre, Thérèse S.; Sterk, Peter J.; Postma, Dirkje S. // PLoS ONE;Feb2014, Vol. 9 Issue 2, p1 

    Background: Inhaled corticosteroids (ICS) reduce exacerbation rates and improve health status but can increase the risk of pneumonia in COPD. The GLUCOLD study, investigating patients with mild-to-moderate COPD, has shown that long-term (2.5-year) ICS therapy induces anti-inflammatory effects....

  • Shingles part one: following the guidance for vaccination. Nazarko, Linda // Nursing & Residential Care;Aug2013, Vol. 15 Issue 8, p538 

    No abstract available.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics